Pro-brain natriuretic peptide is a sensitive marker for detecting cardiac metastases in patients with non-small cell lung cancer

Onkologie

Volumn 32, Issue 7, 2009, Pages 389-392

  Lafaras, Christos ^a,c   Mandala, Eudokia ^b   Saratzis, Athanasios ^a   Platogiannis, Dimitrios ^a   Barbetakis, Nikolaos ^a   Papoti, Sofia ^c   Christopoulou, Maria ^a   Ilonidis, George ^b   Bischiniotis, Theodoros ^a  

^a THEAGENIO CANCER HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Department of Lung Diseases ^*  (Greece)

Author keywords

Cardiac metastases; Echocardiography; Lung cancer; Pro BNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL EVALUATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC DYSFUNCTION; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART METASTASIS; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HEART NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 68149171596     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218368     Document Type: Article

References (23)

1. Reynen K, Köckeritz U, Strasser RH: Metastases to the heart Ann Oncol 2004;15:375-381.
2. Bussani R, De-Giorgio F, Abbate A, Silvestri F: Cardiac metastases. J Clin Pathol 2007;60:27-34.
3. Lafaras C, Bischiniotis T: Metastatic heart disease. Forum of Clinical Oncol 2006;5:177-182.
4. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, vonScheidt W: Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 2001;38: 1934-1941.
5. Kazanegra R, Cheng V, Garcia A, Krishnaswamy P, Gardetto N, Clopton P: A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 2001;7:21-29.
6. Ma K, Banas K, De Bold AJ: Determinants of inducible brain natriuretic peptide promoter activity. Regul Pept 2005;128:169-176.
7. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M: Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997;96:509-516.
8. Maeda K, Tsutamoto T, Wada A, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Kinoshita M: High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000;36:1587-1593.
9. Anand IS, Fisher LD, Chiang Y.T, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN; Val-HeFT Investigators: Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003;107:1278-1283.
10. De Lemos A, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, Hall C, Cannon CP, Braunwald E: The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-1021.
11. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, West-heim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA; Breathing Not Properly Multinational Study Investigators: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161-167.
12. Lainchbury JG, Campbell E, Frampton CM, Yandle TG, Nicholls MG, Richards AM: Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003;42: 728-735.
13. Hunt PJ, Yandle TG, Nicholls MG, Richards AM, Espiner EA: The amino-terminal portion of probrain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun 1995;214:1175-1183.
14. Apple FS, Panteghini M, Ravkilde J, Mair J, Wu AH, Tate J, Pagani F, Christenson RH, Jaffe AS; Committee on Standardization of Markers of Cardiac Damage of the IFCC: Quality specifications for B-type natriuretic peptide assays. Clin Chem 2005;51: 486-493.
15. Van der Merwe DE, Henley R, Lane G, Field R, Frenneaux M, Dunstan F, McDowell I: Effect of different sample types and stability after blood collection of N-terminal pro-B-type natriuretic peptide as measured with Roche Elecsys system. Clin Chem 2004;50:779-780.
16. Mountain CF: Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717.
17. Chiles C, Woodard PK, Gutierrez FR, Link KM: Metastatic involvement of the heart and pericardium: CT and MR imaging. Radiographics 2001;21: 439-449.
18. Bischiniotis TS, Lafaras CT, Platogiannis DN, Moldovan L, Barbetakis NG, Katseas GP: Intrapericardial cisplatin administration after pericardiocentesis in patients with lung adenocarcinoma and malignant cardiac tamponade. HJC 2005;46:388-394.
19. Daniels LB, Maisel AS: Natriuretic peptides. J Am Coll Cardiol 2007;50:2357-2368.
20. Baggish AL, van Kimmenade RR, Januzzi JL Jr: The differential diagnosis of an elevated aminoterminal pro-B-type natriuretic peptide level. Am J Cardiol 2008;101:43-48.
21. Tang WH, Francis GS, Morrow DA, Newby LK, Cannon CP, Jesse RL, Storrow AB: National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation 2007;116:99-109.
22. Lam CS, Burnett JC Jr, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM: Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population. J Am Coll Cardiol 2007;49:1193-1202.
23. Baggish AL, van Kimmenade RR, Januzzi JL Jr: The differential diagnosis of an elevated aminoterminal pro-B-type natriuretic peptide level. Am J Cardiol 2008;101:43-48.